affinity whole health semaglutide GLP-1 and Hormone Therapy for Metabolic — Health Affinity Whole Health (@affinitywholehealth) ·

Like if a woodland fairy got licensed in advanced skincare

Many patients lose significant weight in this period

Dehydration from sustained fluid losses can compromise your bodys electrolyte balance and kidney function

The risk hasnt been established in people, but neither tablet is recommended for anyone with a personal or family history of medullary thyroid carcinoma or MEN2 (multiple endocrine neoplasia type 2)

the increased risk for gallbladder and biliary diseases should be of concern in these patients

Studies from major medical centers indicate that approximately 70% of people regain their lost weight within one year after stopping semaglutide therapy